Search clinical trials for: receptor tyrosine kinase inhibitor
Total 80692 results
-
AstraZenecaDaiichi SankyoNot yet recruiting
-
Shanghai JMT-Bio Inc.Not yet recruiting
-
AstraZenecaDaiichi SankyoRecruitingNon-small Cell Lung CancerAustralia, China, Korea, Republic of, Taiwan
-
Taizhou HospitalNot yet recruitingLung Cancer, Nonsmall Cell
-
Guangzhou Medical UniversityRecruiting
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)United States
-
Ibrahim Halil SahinBayerNot yet recruitingMSI-H Colorectal CancerUnited States
-
Medical College of WisconsinNot yet recruitingFollicular Lymphoma | Burkitt Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma
-
ONYAvaniaNot yet recruitingIntubation Complication | Death; Neonatal | Respiratory Distress Syndrome (Neonatal)United States
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
Guangdong Provincial People's HospitalShanghai Junshi Bioscience Co., Ltd.RecruitingNon-Small Cell Lung Cancer | BRAF V600 Mutation | MET Amplification | MET Exon 14 Skipping Mutation | RET Driver Mutation | Erb-B2 Receptor Tyrosine Kinase Exon 20 MutationChina
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingNeoplasms by Histologic Type | Lymphoma | Lymphoproliferative Disorders | Neoplasms by Site | Renal Cell Carcinoma | Cancer | Solid Tumor | Anaplastic Large Cell Lymphoma | Neuroblastoma | Malignant Neoplasm | Haematological MalignancyUnited Kingdom
-
SCRI Development Innovations, LLCSeagen Inc.Recruiting
-
Ohio State UniversityRecruitingTreatment-resistant SchizophreniaUnited States
-
Cancer Research UKRoyal Marsden NHS Foundation Trust; Hoffmann-La Roche; University of Manchester; University of BirminghamRecruitingSolid Tumor | Haematological MalignancyUnited Kingdom
-
National Cancer Institute (NCI)RecruitingAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid... and other conditionsUnited States, Puerto Rico
-
AstraZenecaRecruitingStage II-IIIB Non-small Cell Lung CarcinomaSpain, Korea, Republic of, Philippines, Italy, United States, Malaysia, Taiwan, Thailand, Hong Kong, United Kingdom, Singapore
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
National Taiwan University HospitalRecruiting
-
Shanghai EpimAb Biotherapeutics Co., Ltd.Labcorp Corporation of America Holdings, IncRecruitingNeoplasms | Neoplasm Metastasis | Metastatic Gastrointestinal Carcinoid TumorUnited States, China
-
National University Hospital, SingaporeBoehringer IngelheimRecruitingNon-Small Cell Lung Cancer | Epidermal Growth Factor Receptor MutationSingapore
-
Calico Life Sciences LLCAbbVieRecruitingAdvanced Solid Tumor CancerUnited States, Korea, Republic of, Spain, Israel, Japan, France
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaRecruitingNon-Small Cell Lung Cancer (NSCLC)United States, Korea, Republic of, Taiwan, Japan
-
Cancer Institute and Hospital, Chinese Academy...RecruitingSmall Cell Lung CarcinomaChina
-
QuantumLeap Healthcare CollaborativeM.D. Anderson Cancer Center; University of Colorado, Denver; University of Pennsylvania and other collaboratorsRecruitingCOVID-19United States
-
Merck Sharp & Dohme LLCRecruitingMelanomaSpain, Poland, United States, Australia, France, Israel, Italy, South Africa, Switzerland, Chile, Greece, Colombia, Hungary, Argentina
-
University Health Network, TorontoBayer; AstraZeneca; Amgen; AnHeart Therapeutics Inc.; Applied Health Research Centre and other collaboratorsRecruitingCancer | Malignancies Multiple | Malignant Solid Tumor | Cancer, Therapy-Related | Molecular Sequence Variation | Genetic Alteration | Gene Fusion | Receptor Tyrosine Kinase Gene Mutation | RTK Family Gene Mutation | Ras (Kras or Nras) Gene MutationCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | High Risk Myelodysplastic Syndrome | Blasts More Than 10 Percent of Bone Marrow Nucleated CellsUnited States
-
Shanghai EpimAb Biotherapeutics Co., Ltd.CovanceRecruitingNeoplasms | Neoplasm Metastasis | Non-Small-Cell Lung CancerUnited States, China
-
AstraZenecaHutchison MediPharmaRecruitingCarcinomaDenmark, Spain, United States, Taiwan, Vietnam, Canada, Korea, Republic of, Brazil, India, Japan, Italy, Puerto Rico, France, Chile
-
Dana-Farber Cancer InstituteAstraZenecaRecruiting
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
National Institute of Allergy and Infectious Diseases...RecruitingHypereosinophilic Syndrome | Eosinophilic Myeloid NeoplasmUnited States
-
Janssen Research & Development, LLCActive, not recruitingNon-Small-Cell Lung CancerUnited States, France, Taiwan, United Kingdom, China, Spain, Japan, Australia, Korea, Republic of, Canada
-
University of UtahActive, not recruitingNon-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor (Disorder)United States
-
Jonsson Comprehensive Cancer CenterEli Lilly and Company; Genentech, Inc.Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Refractory Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer American Joint Committee on Cancer (AJCC) v8 | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8United States
-
MedImmune LLCActive, not recruitingCarcinoma, Non-Small-Cell LungUnited States, Korea, Republic of, Taiwan
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Recurrent Lung Non-Small Cell CarcinomaUnited States
-
AstraZenecaParexelActive, not recruitingNon-small Cell Lung CancerItaly, Spain, United States, China, Germany, Israel
-
QED Therapeutics, Inc.Enrolling by invitationAchondroplasiaUnited States, Spain, United Kingdom, France, Australia, Canada
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IIIA Lung Non-Small Cell Cancer AJCC v7 | Recurrent Lung Non-Small Cell Carcinoma | Stage IIIB Lung Non-Small Cell Cancer AJCC v7 | Stage IV Lung Non-Small Cell Cancer AJCC v7 | Stage III Lung Non-Small Cell Cancer AJCC v7United States, Canada
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Metastatic | Stage IV Non-small Cell Lung Cancer | Non-small Cell Lung Cancer Stage IIIB | EGFR Negative Non-Small Cell Lung CancerUnited States
-
EQRx International, Inc.Terminated
-
Shanghai JMT-Bio Inc.Active, not recruitingLocal Advanced or Metastatic NSCLC | Harboring EGFR Common MutationChina
-
Merck Sharp & Dohme LLCActive, not recruitingCarcinoma, Renal CellSpain, United States, Australia, Canada, Chile, Colombia, France, Hungary, Israel, Korea, Republic of, Netherlands, New Zealand, Poland, United Kingdom
-
CelgeneCompletedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-HodgkinUnited States
-
PfizerActive, not recruitingNeoplasm MetastasisUnited States, Spain, Canada, Korea, Republic of, Australia, Japan, Italy, China
-
Janssen Research & Development, LLCCompletedNeoplasmChina, Taiwan, Korea, Republic of
-
BayerCompletedSolid Tumors Harboring NTRK FusionUnited States, Belgium, Italy, Germany, Australia, Spain, Singapore, Denmark, France, Ireland
-
Puma Biotechnology, Inc.TerminatedSolid Tumors Harboring Somatic HER2 or EGFR Exon 18 MutationsFrance, United States, Spain, Belgium, United Kingdom, Serbia, Australia, Israel, Canada, Denmark, Ireland, Italy, Korea, Republic of